Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 136 participants.

Also called NCT02129634

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 136 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02129634
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Singapore (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02129634. Randomized; double masking; primary purpose treatment. Start 2013-12-27 (actual); primary completion 2018-10-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial
Acronym
SINGA-PACLI
Condition
Peripheral Arterial Disease
Intervention (Device)
CB-PTA
Intervention (Device)
DEB-PTA
Lead sponsor
Singapore General Hospital (class: other)
Collaborator
Tan Tock Seng Hospital (class: other)
Collaborator
Duke-NUS Graduate Medical School (class: other)
Collaborator
Singapore Clinical Research Institute (class: other)

Record details

Record id
cardio:ct-nct02129634
Content hash
8012b60345495b79be530b434a1d8669f11119085f6dd0028a5f5de3d1e49e4b